Banner
Pilot Study: Fibromyalgia Fatigue Improved By TENS Therapy

Fibromyalgia is the term for a poorly-understood condition where people experience pain and fatigue...

High Meat Consumption Linked To Lower Dementia Risk

Older people who eat large amounts of meat have a lower risk of dementia and cognitive decline...

Long Before The Inca Colonized Peru, Natives Had A Thriving Trade Network

A new DNA analysis reveals that long before the Incan Empire took over Peru, animals were...

Mesolithic People Had Meals With More Tradition Than You Thought

The common imagery of prehistoric people is either rooting through dirt for grubs and picking berries...

User picture.
News StaffRSS Feed of this column.

News Releases From All Over The World, Right To You... Read More »

Blogroll

It may be possible to assess the risk of developing dementia by analyzing information gathered during routine visits to the family doctor, according to research published in the open access journal BMC Medicine.

The time is right for a broad range of stakeholders to push for a health care information economy founded on the basic principle that patients should have control over their data, Boston Children's Hospital informatics researchers say in a Perspective article in The New England Journal of Medicine. The technologies, demand and benefits are there, they note; what remains are the incentives and will to make it happen.

NEW YORK, NY (January 20, 2016)--A multicenter research team has identified a biomarker that predicts which stage II colon cancer patients may benefit from chemotherapy after surgery to prevent a recurrence of their disease.

The study was published today in the online edition of the New England Journal of Medicine.

The majority of patients with stage II colon cancer--cancer that has grown into or through the outer layer of the colon but has not spread to lymph nodes or distant organs--are cured by surgery alone. However, about 15 to 20 percent of these patients eventually relapse and die of metastatic disease.

From the middle-school child considering the premier brands of soccer shoes, to the college graduate weighing which graduate test prep course to take, a common marketing message from consumer brands is "you will perform better with us."

In a new study, Frank Germann, of the Department of Marketing in the University of Notre Dame's Mendoza College of Business, and colleagues Aaron Garvey of the University of Kentucky and Lisa Bolton of Penn State University examine if such performance brands can cause a placebo effect.

Building on a 30-year, three-generation study of depressed individuals, their children and offspring, a study published in the journal Psychiatry Research: Neuroimaging provides a better understanding of the familial risk for depression and the role neuroplasticity might have in increasing the risk of developing depression.

The research by scientists at Children's Hospital Los Angeles and Columbia University shows a link between a particular allele for serotonin found at a higher frequency in those at risk of depression because of family history, and those who go on to develop major depressive disorder.

Caltech researchers have found evidence of a giant planet tracing a bizarre, highly elongated orbit in the outer solar system. The object, which the researchers have nicknamed Planet Nine, has a mass about 10 times that of Earth and orbits about 20 times farther from the sun on average than does Neptune (which orbits the sun at an average distance of 2.8 billion miles). In fact, it would take this new planet between 10,000 and 20,000 years to make just one full orbit around the sun.

The researchers, Konstantin Batygin and Mike Brown, discovered the planet's existence through mathematical modeling and computer simulations but have not yet observed the object directly.